2 vídeos

Biomarkers in HER2-Positive breast cancer: from the IHC Era to multi-omics in tissue and blood

Dr. Juan Miguel Cejalvo: Hospital Clínic de Valencia/ INCLIVA

Dr. Pablo Tolosa: Hospital 12 de Octubre

2 vídeos

Integration of clinically available biomarkers for treatment escalation or de-escalation in early and advanced HER2-Positive breast cancer

Dr. Tomás Pascual: Hospital Clínic de Barcelona

Dra. Mireia Margelí: Institut Català d’Oncologia (ICO), Barcelona

2 vídeos

Changing the paradigm of first-line treatment: integrating the latest evidence to optimize patient care

Prof. Dra. Sibylle Loibl: German Breast Group, Neu-Isenburg, Germany

Dra. Cristina Saura: Hospital Universitario Vall d’Hebron, Barcelona

2 vídeos

Enhancing second-line treatment options and beyond: navigating current approved therapies and promising emerging drugs

Dra. Sonia Pernas: Institut Català d’Oncologia (ICO), Barcelona

Dr. Rodrigo Sánchez-Bayona: Hospital 12 de Octubre, Madrid

2 vídeos

Cutting-edge approaches to enhancing quality of life: proactive adverse event management and education programs

Dra. Nadia Harbeck: LMU University Hospital, Munich

Dr. Santiago Escrivá : Hospital Universitario Vall d’Hebron, Barcelona